This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Diabetes Type 2
and you are
The phase for this study is not defined.
Show me locations

The purpose

Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.

Provided treatments

  • Drug: Cabergoline

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01459601. The sponsor of the trial is Mashhad University of Medical Sciences and it is looking for 10 volunteers for the current phase.
Official trial title:
Cabergoline Effects on Blood Sugar Control in Type 2 Diabetics